Is Eriomin Trending?

What the data shows

Search interest in Eriomin has risen over the period: the yearly high moved from 0 in 2021 to 93 in 2025, against an all-time high of 100 in August 2024.

• Peak interest: August 2024 (index 100)
• Recent level (last 12 weeks): index 31 of 100
• Change, first vs. latest 12 months: rose from no measurable interest
• Period covered: March 2021 – March 2026

Values are Google's relative search index, where 100 is the highest point in the period — not absolute search volume.

About Eriomin

Eriomin is a patented citrus flavonoid extract, sold as an ingredient rather than as a brand in its own right. Its commercial positioning is as "natural GLP-1 support" — a category that did not meaningfully exist before prescription GLP-1 drugs became household names.

The search data is unusually clean on this point. Interest is flat at zero through 2021, 2022 and 2023, and only begins in 2024. There is no long tail of prior curiosity to explain away: this is a term that arrived, and it arrived immediately after the drugs it references entered mainstream conversation.

What has happened since is a move down the supply chain. An ingredient of this kind normally lives in business-to-business channels, sold by suppliers to formulators. Eriomin has since appeared in finished consumer products on major US retail shelves, often formulated alongside other bioactives to tell a combined gut, glucose and satiety story. Industry forecasters have grouped it with berberine as a leading ingredient in this category going into 2026. The pattern worth watching is whether it cascades into European and private-label formulations, which is the usual next step.

Two cautions. The first is statistical: this is a low-volume term, and the Google index is relative to its own history, so the single highest week — August 2024 — reflects a spike against a very small base rather than a peak of mass interest. The steadier signal is the yearly average, which has roughly doubled in each year since 2024. The second is semantic. "Natural GLP-1 support" is a marketing category, not a statement of equivalence with the prescription drugs that created the demand, and the search trend measures interest in the phrase rather than any settled comparison between the two.

More in Supplements

Compare Eriomin with other supplements trends.